CREBBP and rectum adenocarcinoma: Analyzing The Cancer Genome Atlas (TCGA) [38], we found significantly lower CREBBP and EP300 expression in tumors of patients with colon adenocarcinoma (COAD) and rectum adenocarcinoma (READ) compared with matched nonmalignant tissues (Fig. S6A,B).